DB19121InvestigationalProtein Based Therapies
Redasemtide is under investigation in clinical trial NCT05953480 (A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke).
- Also known as
- Met-gly-lys-gly-asp-pro-lys-lys-pro-arg-gly-lys-met-ser-ser-tyr-ala-phe-phe-val-gln-thr-cys-arg-glu-glu-his-lys-lys-lys-his-pro-asp-ala-ser-val-asn-phe-ser-glu-phe-ser-lys-lys
- Code names
- S-005151
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Redasemtide, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account